Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Orexo
Orexo
Orexo is a pharmaceutical company based in Uppsala, Sweden initially financed with venture capital provided by HealthCap.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zubsolv
Buprenorphine
,
Naloxone
2013-07-03
2024-2038
Septic shock
,
Pain
,
Opioid-related disorders
,
Heroin dependence
,
Respiration disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Buprenorphine
healthy volunteers/patients
,
heroin dependence
,
opioid-related disorders
,
substance-related disorders
,
hepatitis c
,
liver failure
,
chronic hepatitis b
,
hepatic insufficiency
,
chronic hepatitis c
,
hepatitis
,
hepatitis a
,
pain
,
opiate overdose
,
drug overdose
Naloxone
pain
,
constipation
,
neoplasms
,
opioid-induced constipation
,
postoperative pain
,
low back pain
,
back pain
,
spinal cord diseases
,
spinal diseases
,
chronic pain
,
cancer pain
,
peripheral nervous system diseases
,
opiate overdose
,
drug overdose
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use